HTG Molecular Diagnostics to Announce Third Quarter 2021 Financial Results and Host Conference Call on Wednesday, November 10

Rhea-AI Summary

HTG Molecular Diagnostics (Nasdaq: HTGM) announced it will report its Q3 financial results on November 10, 2021, after market close. Management will hold a conference call at 4:30 pm ET to discuss the results and provide a corporate update. HTG is focused on advancing precision medicine through its transcriptome-wide technology, aiming to enhance translational research and clinical diagnostics across various diseases. The company has established partnerships with biopharma leaders and academic institutes to innovate its RNA platform technologies.

Positive

• HTG is advancing precision medicine through innovative transcriptome-wide technology.
• Partnerships with biopharma leaders and institutes enhance HTG's research capabilities.
• Upcoming Q3 financial results and investor call may provide insights into company performance.

Negative

• None.

TUCSON, Ariz., Nov. 02, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company advancing precision medicine through its transcriptome-wide technology, today announced that it will report its financial results for the third quarter ended September 30, 2021 after the market close on Wednesday, November 10, 2021. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30 pm ET.

Conference Call & Webcast Details
Date:	Wednesday, November 10
Time:	4:30 pm ET
Toll Free:	877-407-0789
International:	201-689-8562
Conference ID:	13723995
Webcast:	https://78449.themediaframe.com/dataconf/productusers/vvdb/mediaframe/46912/indexl.html

About HTG:

HTG is accelerating precision medicine from diagnosis to treatment by harnessing the power of transcriptome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas.

Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG’s proprietary RNA platform technologies are designed to make the development of life science tools and diagnostics more effective and efficient and to unlock a differentiated and disruptive approach to transformative drug discovery. For more information visit www.htgmolecular.com.

Contact:
Ashley R. Robinson
LifeSci Advisors, LLC
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com 

FAQ

When will HTG Molecular Diagnostics report its Q3 financial results?

HTG Molecular Diagnostics will report its Q3 financial results on November 10, 2021, after market close.

What time is the conference call for HTG's financial results?

The conference call to discuss HTG's financial results will be held at 4:30 pm ET on November 10, 2021.

What is the focus of HTG Molecular Diagnostics?

HTG focuses on advancing precision medicine through transcriptome-wide profiling and developing life science tools.

How can I access the webcast for the HTG conference call?

The webcast for the HTG conference call can be accessed at https://78449.themediaframe.com/dataconf/productusers/vvdb/mediaframe/46912/indexl.html.